SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on June 30, 2022. The report details the closing of an underwritten public offering of common stock. Note: The request metadata referenced "Streamex Corp.," but the filing text explicitly identifies the registrant as BioSig Technologies, Inc.
Key Financial Metrics and Transaction Details
- Offering Size: 4,341,667 shares of Common Stock ($0.001 par value).
- Warrants Issued: Warrants to purchase up to 217,083 shares of Common Stock.
- Warrant Exercise Price: $0.90 per share.
- Underwriter: Laidlaw & Company (UK) Ltd.
- Closing Date: June 29, 2022.
- Revenue/Profit/Cash Flow: The filing text does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the period.
Material Changes
The primary material event is the completion of the equity offering on June 29, 2022, following an underwriting agreement entered into on June 24, 2022, and amended on June 28, 2022. This transaction resulted in the issuance of new shares and warrants, increasing the company's capital base.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future performance, or specific risk factors beyond the standard disclosure of the equity offering. The press release regarding the closing is attached as Exhibit 99.1 but its specific content is not detailed in the provided text.
Investor Verification Checklist
- Verify the total gross proceeds raised from the sale of 4,341,667 shares (offering price per share is not stated in the text).
- Confirm the dilution impact of the new shares and the 217,083 warrants issued.
- Review the attached Press Release (Exhibit 99.1) for the specific use of proceeds.
- Check the company's updated share count and capitalization table post-closing.